HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prop 65 Litigators Turning Sights On Beauty Industry, Lawyer Says

This article was originally published in The Rose Sheet

Executive Summary

Prop 65 suits tend to hit industries in waves, and there are indications that the beauty industry is next, says Angela Diesch, attorney for Sacrament, Calif.-based Greenberg Traurig. Marketers of products containing methyl eugenol, lead or cocamide DEA should ensure they are complying with the California law.

You may also be interested in...

NGO’s Prop 65 Lawsuit Targets Undisclosed Cocamide DEA

Oakland, Calif.-based Center for Environmental Health calls out more than 100 manufacturers and retailers of cocamide deithanolamine-containing products that it says are noncompliant with the state’s Proposition 65 regulation. CEH has filed suit against four of them.

“Devil Is In The Details” On Prop 65 Reform Benefits – AHPA

California Gov. Jerry Brown wants to cap attorney fees and settlement funds in Prop 65 cases and require expanded plaintiff disclosures and demonstrations of supporting evidence before litigation can proceed, among other proposed measures designed to reduce frivolous lawsuits against industry members.

Aggressive Claims, FDA Warnings Make Beauty A Bull’s Eye For Litigation

Class-action suits against beauty firms on the rise as industry pushes the envelope with claims and FDA warning letters draw attention from class-action law firms, legal experts note. Hogan Lovells attorney Mark Goodman says: “I don’t see this [trend] going away anytime soon.”

Related Content

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts